Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Stakeholders To Address CMS Advisory Panel On Outpatient Payment Issues

This article was originally published in The Gray Sheet

Executive Summary

Prosthetic urologists will be among device stakeholders seeking improved Medicare outpatient payment in 2005 when CMS' Ambulatory Payment Classification Advisory Panel convenes in Baltimore Sept. 1-3

You may also be interested in...



APC Panel Calls For External Data To Resolve Outpatient Payment Issues

CMS' Ambulatory Payment Classification Advisory Panel recommended the agency incorporate external data to settle discrepancies with device-related payment groupings in the outpatient prospective payment system

APC Panel Calls For External Data To Resolve Outpatient Payment Issues

CMS' Ambulatory Payment Classification Advisory Panel recommended the agency incorporate external data to settle discrepancies with device-related payment groupings in the outpatient prospective payment system

IVD Manufacturers, Labs Should Be Subject To Same Standards – AdvaMed

FDA should allow in vitro diagnostic manufacturers to partake of some of the same regulatory flexibility that clinical labs currently enjoy, AdvaMed suggests to HHS in 1Aug. 23 comments on stimulating medical technology innovation

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT020812

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel